Levetiracetam
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
Molecular Identity
Levetiracetam
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID: 5284583
Levetiracetam is a pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine. It has a role as an anticonvulsant, a xenobiotic and an environmental contaminant.
2D Structure
Properties
C8H14N2O2
Molecular Formula
170.21
Molecular Weight
g/mol
170.1055
Exact Mass
Da
-0.3
XLogP
Drug-like (Lipinski: < 5)
63.4
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
2
H-Bond Acceptors
203
Complexity
SMILES
Canonical SMILES
SMILES: CCC(C(=O)N)N1CCCC1=OIsomeric SMILES
SMILES: CC[C@@H](C(=O)N)N1CCCC1=OSynonyms(20)
Levetiracetam102767-28-2Keppra(2S)-2-(2-oxopyrrolidin-1-yl)butanamideKeppra XRSpritamUCB-L 059ucb L059mateverLevetiracetameLevetiracetamumLevetiracetam tevaUCB-L059Elepsia(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Levetiracetam
Loading drug network...